Use of molidustat, a hypoxia‐inducible factor prolyl hydroxylase inhibitor, in chronic kidney disease‐associated anemia in cats
Abstract Background Erythropoietic effects of molidustat, a hypoxia‐inducible factor prolyl hydroxylase (HIF‐PH) inhibitor, were previously demonstrated in healthy cats. Objective To evaluate the safety and erythropoietic effects of daily PO administration of molidustat in anemic cats with chronic k...
| Հիմնական հեղինակներ: | , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Wiley
2024-01-01
|
| Շարք: | Journal of Veterinary Internal Medicine |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://doi.org/10.1111/jvim.16807 |